These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

63 related articles for article (PubMed ID: 24215309)

  • 21. Diabetes, cancer and treatment - a mini-review.
    Vestergaard P; Starup-Linde J
    Curr Drug Saf; 2013 Nov; 8(5):292-5. PubMed ID: 24215309
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Biphasic insulin aspart 30: literature review of adverse events associated with treatment.
    Davidson J; Vexiau P; Cucinotta D; Vaz J; Kawamori R
    Clin Ther; 2005; 27 Suppl B():S75-88. PubMed ID: 16519039
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Insulin glargine: a systematic review of a long-acting insulin analogue.
    Wang F; Carabino JM; Vergara CM
    Clin Ther; 2003 Jun; 25(6):1541-77, discussion 1539-40. PubMed ID: 12860485
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prandial premixed insulin analogue regimens versus basal insulin analogue regimens in the management of type 2 diabetes: an evidence-based comparison.
    Ilag LL; Kerr L; Malone JK; Tan MH
    Clin Ther; 2007; 29 Spec No():1254-70. PubMed ID: 18046926
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Update on insulin analogues.
    Drug Ther Bull; 2004 Oct; 42(10):77-80. PubMed ID: 15491022
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Insulin analogues in pregnancy and specific congenital anomalies: a literature review.
    de Jong J; Garne E; Wender-Ozegowska E; Morgan M; de Jong-van den Berg LT; Wang H
    Diabetes Metab Res Rev; 2016 May; 32(4):366-75. PubMed ID: 26431249
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Diabetes, insulin, insulin analogues, and cancer].
    Müssig K; Staiger H; Kantartzis K; Fritsche A; Kanz L; Häring HU
    Dtsch Med Wochenschr; 2010 May; 135(18):924-9. PubMed ID: 20425680
    [TBL] [Abstract][Full Text] [Related]  

  • 28. CARING (CAncer Risk and INsulin analoGues): the association of diabetes mellitus and cancer risk with focus on possible determinants - a systematic review and a meta-analysis.
    Starup-Linde J; Karlstad O; Eriksen SA; Vestergaard P; Bronsveld HK; de Vries F; Andersen M; Auvinen A; Haukka J; Hjellvik V; Bazelier MT; Boer Ad; Furu K; De Bruin ML
    Curr Drug Saf; 2013 Nov; 8(5):296-332. PubMed ID: 24215312
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparison of insulin glargine and NPH insulin in the treatment of type 2 diabetes: a review of clinical studies.
    Duckworth W; Davis SN
    J Diabetes Complications; 2007; 21(3):196-204. PubMed ID: 17493554
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Diabetes and cancer risk: oncologic considerations].
    Rosta A
    Orv Hetil; 2011 Jul; 152(29):1144-55. PubMed ID: 21712179
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Insulin glulisine: efficacy and safety compared with other rapid-acting insulin analogues.
    Kamal AD; Bain SC
    Expert Opin Drug Saf; 2007 Jan; 6(1):5-7. PubMed ID: 17181446
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Evidence based therapy with insulin in diabetic patients].
    Jermendy G
    Orv Hetil; 2005 Feb; 146(8):341-52. PubMed ID: 15803885
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Humalog (lispro) for type 2 diabetes.
    Esposito K; Capuano A; Giugliano D
    Expert Opin Biol Ther; 2012 Nov; 12(11):1541-50. PubMed ID: 23043233
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Insulin detemir: a review of its use in the management of type 1 and 2 diabetes mellitus.
    Chapman TM; Perry CM
    Drugs; 2004; 64(22):2577-95. PubMed ID: 15516157
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Premixed insulin analogues for the treatment of diabetes mellitus.
    Garber AJ
    Drugs; 2006; 66(1):31-49. PubMed ID: 16398567
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Intermediate and long-acting insulins: a review of NPH insulin, insulin glargine and insulin detemir.
    Peterson GE
    Curr Med Res Opin; 2006 Dec; 22(12):2613-9. PubMed ID: 17166343
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Safety of insulin analogues as compared with human insulin in pregnancy.
    Toledano Y; Hadar E; Hod M
    Expert Opin Drug Saf; 2016 Jul; 15(7):963-73. PubMed ID: 27145344
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Insulin aspart: a review of its use in the management of type 1 or 2 diabetes mellitus.
    Reynolds NA; Wagstaff AJ
    Drugs; 2004; 64(17):1957-74. PubMed ID: 15329046
    [TBL] [Abstract][Full Text] [Related]  

  • 39. New insulins and the risk of cancer.
    Danne T; Bolinder J
    Int J Clin Pract Suppl; 2010 Feb; (166):26-8. PubMed ID: 20377661
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.